MediFind
Condition

Lymphangioleiomyomatosis

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis (LAM)
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Pulmonary Rehabilitation (PR)
  • Number of Patients: 58
  • Published —
This study evaluated the benefits of pulmonary rehabilitation (a program to help a patient learn to breathe and function at the highest level possible; PR) in patients with advanced lymphangioleiomyomatosis (progressive disease that can affect the lungs, lymph nodes and kidneys; LAM).
Latest Advance
Study
  • Condition: COVID-19
  • Journal: American journal of medical genetics. Part A
  • Treatment Used: mTOR Inhibitors
  • Number of Patients: 26
  • Published —
The study researched the use of mTOR inhibitors in patients with COVID-19.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis
  • Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • Treatment Used: Lung Transplantation
  • Number of Patients: 76
  • Published —
In this study, researchers evaluated the outcomes of undergoing lung transplantation for the treatment of lymphangioleiomyomatosis.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis
  • Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • Treatment Used: mTOR Inhibitors
  • Number of Patients: 8
  • Published —
In this study, researchers evaluated the safety of continuing mTOR inhibitors for lymphangioleiomyomatosis patients waitlisted for a lung transplant.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis (LAM)
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Yoga
  • Number of Patients: 26
  • Published —
This study evaluated the effects of yoga on exercise capacity and quality of life in patients with lymphangioleiomyomatosis (lung disease caused by the abnormal growth of smooth muscle cells, especially in the lungs and lymphatic system; LAM).
Latest Advance
Study
  • Condition: Pulmonary Lymphangioleiomyomatosis
  • Journal: Respiratory medicine
  • Treatment Used: Simvastatin
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the safety of using simvastatin in combination with sirolimus or everolimus for the treatment of pulmonary lymphangioleiomyomatosis.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Sirolimus therapy
  • Number of Patients: 142
  • Published —
The study researched the long-term outcomes of sirolimus therapy for lymphangioleiomyomatosis.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis (LT)
  • Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • Treatment Used: Lung Transplantation (LT)
  • Number of Patients: 138
  • Published —
This study derived disease-specific outcomes following lung transplantation (LT) in patients with lymphangioleiomyomatosis (invasion of smooth muscle cells in lungs; LAM).
Latest Advance
Study
  • Condition: Cystic Lung Disease, Lymphangioleiomyomatosis (LAM)
  • Journal: Chest
  • Treatment Used: Radiation Doses
  • Number of Patients: 105
  • Published —
This study evaluated CT scans performed at radiation doses equivalent to that of a posteroanterior and lateral chest radiograph series in the cystic lung disease lymphangioleiomyomatosis (LAM).
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Sirolimus
  • Number of Patients: 0
  • Published —
This study evaluated the efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis.
Latest Advance
Study
  • Condition: Tuberous sclerosis complex/Sporadic lymphangioleiomyomatosis
  • Journal: PloS one
  • Treatment Used: Everolimus
  • Number of Patients: 112
  • Published —
This study evaluated angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
Latest Advance
Study
  • Condition: Lymphangioleiomyomatosis
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Mammalian target of the rapamycin inhibitors
  • Number of Patients: 0
  • Published —
The aim of the study was to understand the effectiveness and safety of mammalian target of the rapamycin blockers (blocking mammalian target of rapamycin may cause the cancer cells to die) in lymphangioleiomyomatosis patients.